EARNINGS (LOSS) PER SHARE (Tables)

6 Months Ended

Jun. 30, 2024

The reconciliations of the net loss and the weighted average number of shares used in the computations of basic and diluted loss per share are as follows:


	Three Months Ended June 30,				Six Months Ended June 30,
	2024		2023		2024		2023
Numerator:
Net loss and comprehensive loss	$	(1,938)	$	(14,036)	$	(20,293)	$	(26,476)


Net loss and comprehensive loss - diluted	$	(1,938)	$	(14,036)	$	(20,293)	$	(26,476)

Denominator:
Weighted-average shares of common stock - basic	195,138,473		194,756,391		195,135,057		194,405,562

Weighted-average shares of common stock - diluted	195,138,473		194,756,391		195,135,057		194,405,562

Loss per common share:
Basic	$	(0.01)	$	(0.07)	$	(0.10)	$	(0.14)
Diluted	$	(0.01)	$	(0.07)	$	(0.10)	$	(0.14)

Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share

The following table summarizes weighted average instruments that may, in the future, have a dilutive effect on earnings (loss) per share, but were excluded from consideration in the computation of diluted net loss per share for the three and six months ended June 30, 2024 and 2023, because the impact of including them would have been anti-dilutive:


	Three Months Ended June 30,		Six Months Ended June 30,
	2024	2023	2024	2023
Stock options	28,027,491	29,248,553	27,840,551	28,941,749
Warrants (derivative liabilities and equity)	88,564,891	86,097,189	88,237,693	86,043,865
Unvested restricted stock awards	1,861	376,980	1,861	746,843
	116,594,243	115,722,722	116,080,105	115,732,457